Ercros, S.A.

MCE ECR.MC

Ercros, S.A. Operating Income Margin for the year ending December 31, 2023: 1.80%

Ercros, S.A. Operating Income Margin is 1.80% for the year ending December 31, 2023, a -80.52% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Ercros, S.A. Operating Income Margin for the year ending December 31, 2022 was 9.23%, a 37.55% change year over year.
  • Ercros, S.A. Operating Income Margin for the year ending December 31, 2021 was 6.71%, a 155.50% change year over year.
  • Ercros, S.A. Operating Income Margin for the year ending December 31, 2020 was 2.63%, a -38.74% change year over year.
  • Ercros, S.A. Operating Income Margin for the year ending December 31, 2019 was 4.29%, a -33.34% change year over year.
Key data
Date Operating Income Margin EBT Margin Net Income Margin EBITDA Margin
Market news
Loading...
MCE: ECR.MC

Ercros, S.A.

CEO Mr. Antonio Zabalza Marti
IPO Date Jan. 3, 2000
Location Spain
Headquarters Avinguda Diagonal, 593-595
Employees 1,253
Sector Health Care
Industries
Description

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers. This segment's products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; to produce compound feed and in cooling equipment. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding powders, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing chipboards, and decorative laminates and plywoods, as well as resins, paints, and varnishes in the furniture and decoration industry; plugs and switches in the electrical components sector; and household, sanitary, and packaging materials in the textile tanning industry. The Pharmacy division engages in the production of raw materials and intermediate products from antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal agents. This segment's products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, calcium and sodium fosfomycin, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

Similar companies

FAE.MC

Faes Farma, S.A.

USD 3.46

-1.45%

ENC.MC

ENCE Energía y Celulosa, S.A.

USD 3.25

1.25%

StockViz Staff

January 15, 2025

Any question? Send us an email